{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"semax-insomnia","title":"Semax for Insomnia: Evidence-Graded Review","body":"## What's breaking down\n\nInsomnia often involves disrupted neural repair processes. BDNF levels can drop under chronic stress or cognitive load, limiting the brain's ability to form and maintain connections overnight. An ACTH fragment like Semax is studied mainly for upregulating BDNF and supporting attention and memory recovery in specific models, not for direct sedation.\n\nIf neural plasticity pathways are part of the picture, the discussion centers on whether targeted support there could aid recovery rather than simply suppressing wakefulness signals.\n\n## Why Semax might help you\n\n1. What keeps failing: BDNF decline and neural stress responses that interfere with the brain's overnight consolidation and repair cycles.\n2. What Semax is studied to do: Increase BDNF protein and mRNA in rat hippocampus and basal forebrain, alongside effects on attention in small human pilots.\n3. Therefore for you: If your insomnia links to cognitive fatigue or reduced neuroplasticity rather than pure hyperarousal, Semax enters the conversation because it is researched for repair-layer support, not because it acts as a sleep mask.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive layer. Any other approaches would address separate layers such as inflammation or direct sleep architecture if part of a broader profile.\n\n## What the evidence actually shows\n\nNo dedicated human clinical trials exist that test Semax specifically as a treatment for insomnia (human tier: none found).\n\nPreclinical tier: Rat studies demonstrate Semax binds sites in the basal forebrain and raises BDNF protein levels within hours after intranasal dosing at 50–250 µg/kg. One study showed a 1.4-fold BDNF increase in hippocampus plus elevated trkB phosphorylation and improved conditioned avoidance performance (Dolotov et al., 2006, rat model).\n\nAnother rat study linked Semax to normalized behavior in anxiety/depression models and gene expression changes favoring neurotransmission over inflammation (preclinical tier).\n\nHuman tier: Small Russian pilots report improved attention and short-term memory after intranasal Semax (250–1000 µg/kg range) with EEG shifts resembling other neuroprotective agents. A study of 110 post-stroke patients using 6000 µg/day intranasal noted higher plasma BDNF (human tier, limited scale, stroke population). A 24-person healthy volunteer fMRI pilot showed acute changes in default mode network activity after 1.2 mg intranasal (preclinical-adjacent human data).\n\nAnecdotal tier: Multiple Reddit reports describe sleep disruption, reduced sleep quality, vivid or intense dreams, or outright insomnia when Semax is dosed in the afternoon or later. Several users note the activating profile makes late dosing counterproductive for rest (anecdotal tier).\n\n## What scientists say\n\nResearchers frame Semax as a nootropic and neuroprotective agent with BDNF-related mechanisms. Publications emphasize cognitive recovery after ischemia rather than sleep promotion. One review notes the absence of large Western RCTs for cognitive claims in healthy populations (mechanistic tier for BDNF; speculative tier for insomnia application).\n\n## What people say on Reddit\n\nUsers frequently report that Semax sharpens focus but can impair sleep architecture or cause early-morning awakenings if taken past midday. A subset describes poorer overall sleep quality and more intense dreaming during use. A minority mention neutral or occasionally better rest when dosed strictly in the morning, with emphasis on pairing with solid baseline habits (anecdotal tier).\n\n## What people say on X\n\nLimited public discussion specific to Semax and insomnia appears in available searches. Posts that mention the compound focus more on cognitive or mood effects than sleep outcomes (anecdotal tier, sparse data).\n\n## What we do not know\n\nNo controlled human data exist on Semax for primary insomnia. Long-term effects on sleep architecture, dose-response for any sleep-related outcomes, and interactions with common insomnia drivers remain unstudied in rigorous trials. Translation from rat BDNF data to human insomnia is speculative.\n\n## Safety and limits\n\nReported effects include nasal irritation, headache, and occasional overstimulation or sleep interference when timing is off (anecdotal and mechanistic tiers). Sources advise morning administration to avoid carryover into rest periods. Evidence base remains primarily Russian clinical use for stroke recovery plus preclinical work; large independent Western trials for sleep applications are absent. All claims above are labeled by evidence tier and separated by study type.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/semax-insomnia/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No dedicated human clinical trials test Semax specifically for insomnia treatment.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the absence of direct evidence for the queried use case.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax increases BDNF protein levels in hippocampus and basal forebrain within hours after intranasal dosing.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Core mechanistic finding cited across multiple papers.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Small human pilots report improved attention and BDNF changes post-stroke or in healthy volunteers after intranasal Semax.","section":"What the evidence actually shows","tier":"human","source_ids":["s3","s4"],"source_status":"sourced","why_material":"Documents the limited existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users commonly report sleep disruption or insomnia when Semax is dosed later in the day.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5"],"source_status":"sourced","why_material":"Captures user-reported patterns on sleep effects.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Semax is studied primarily for cognitive recovery and BDNF support rather than sedation.","section":"Why Semax might help you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Frames the repair-versus-suppression distinction.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"Human research to suggest prevention of dementia and cognitive aging. In one pilot study in 24 healthy subjects...","summary":"Notes limited pilot studies and absence of large Western RCTs for most claims.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:09:03.485Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"fcc0928816c885fc0e7da3346063ce0cb9ffd46aab49cae8ffc37b48e5a50bb1"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16635254/","title":"Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain","quote":"Semax stimulates the synthesis of brain-derived neurotrophic factor (BDNF)...","summary":"Rat study demonstrating BDNF increase after intranasal Semax.","claim_ids":["c2","c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:09:03.485Z","link_status":"ok","quote_status":"unverified","prev":"fcc0928816c885fc0e7da3346063ce0cb9ffd46aab49cae8ffc37b48e5a50bb1","hash":"93bb364c231fcdc75cab2fa544c0f949330c34a064e76166007060419b2c30ac"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16996037/","title":"Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus","quote":"Semax affects cognitive brain functions by modulating the expression and the activation of the hippocampal BDNF/trkB system.","summary":"Additional rat data on BDNF and cognitive tasks.","claim_ids":["c2","c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:09:03.485Z","link_status":"ok","quote_status":"verified","prev":"93bb364c231fcdc75cab2fa544c0f949330c34a064e76166007060419b2c30ac","hash":"844fcdbd290d9c1fabfc24561227bc8482ab3b9d65fc6b6a1a15d17347456fd1"},{"id":"s4","type":"other","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"A study of 110 patients with stroke reported that treatment with semax increased plasma BDNF levels.","summary":"Human post-stroke BDNF observation.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:09:03.485Z","link_status":"ok","quote_status":"unverified","prev":"844fcdbd290d9c1fabfc24561227bc8482ab3b9d65fc6b6a1a15d17347456fd1","hash":"43e507096f4bbb420e5e848c3ba5cc0036e1eb384a77d98f5ce4fac1207de794"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/Nootropics/comments/lfsp8z/insomnia_after_semax/","title":"Insomnia after semax?","quote":"Now i go to bed at 10pm and wake up at 3am... Semax is an ACTH fragment... stress induced insomnia with Semax.","summary":"User reports linking Semax to sleep disruption.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:09:03.485Z","link_status":"ok","quote_status":"unverified","prev":"43e507096f4bbb420e5e848c3ba5cc0036e1eb384a77d98f5ce4fac1207de794","hash":"a2e6b63b7511735e700324dd38d21393bb50656440331759143bb1f6a745ecef"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:09:04.219Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Semax for Insomnia: Evidence-Graded Review","register":"source_ledger","body":"## What's breaking down\n\nInsomnia often involves disrupted neural repair processes. BDNF levels can drop under chronic stress or cognitive load, limiting the brain's ability to form and maintain connections overnight. An ACTH fragment like Semax is studied mainly for upregulating BDNF and supporting attention and memory recovery in specific models, not for direct sedation.\n\nIf neural plasticity pathways are part of the picture, the discussion centers on whether targeted support there could aid recovery rather than simply suppressing wakefulness signals.\n\n## Why Semax might help you\n\n1. What keeps failing: BDNF decline and neural stress responses that interfere with the brain's overnight consolidation and repair cycles.\n2. What Semax is studied to do: Increase BDNF protein and mRNA in rat hippocampus and basal forebrain, alongside effects on attention in small human pilots.\n3. Therefore for you: If your insomnia links to cognitive fatigue or reduced neuroplasticity rather than pure hyperarousal, Semax enters the conversation because it is researched for repair-layer support, not because it acts as a sleep mask.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive layer. Any other approaches would address separate layers such as inflammation or direct sleep architecture if part of a broader profile.\n\n## What the evidence actually shows\n\nNo dedicated human clinical trials exist that test Semax specifically as a treatment for insomnia (human tier: none found).\n\nPreclinical tier: Rat studies demonstrate Semax binds sites in the basal forebrain and raises BDNF protein levels within hours after intranasal dosing at 50–250 µg/kg. One study showed a 1.4-fold BDNF increase in hippocampus plus elevated trkB phosphorylation and improved conditioned avoidance performance (Dolotov et al., 2006, rat model).\n\nAnother rat study linked Semax to normalized behavior in anxiety/depression models and gene expression changes favoring neurotransmission over inflammation (preclinical tier).\n\nHuman tier: Small Russian pilots report improved attention and short-term memory after intranasal Semax (250–1000 µg/kg range) with EEG shifts resembling other neuroprotective agents. A study of 110 post-stroke patients using 6000 µg/day intranasal noted higher plasma BDNF (human tier, limited scale, stroke population). A 24-person healthy volunteer fMRI pilot showed acute changes in default mode network activity after 1.2 mg intranasal (preclinical-adjacent human data).\n\nAnecdotal tier: Multiple Reddit reports describe sleep disruption, reduced sleep quality, vivid or intense dreams, or outright insomnia when Semax is dosed in the afternoon or later. Several users note the activating profile makes late dosing counterproductive for rest (anecdotal tier).\n\n## What scientists say\n\nResearchers frame Semax as a nootropic and neuroprotective agent with BDNF-related mechanisms. Publications emphasize cognitive recovery after ischemia rather than sleep promotion. One review notes the absence of large Western RCTs for cognitive claims in healthy populations (mechanistic tier for BDNF; speculative tier for insomnia application).\n\n## What people say on Reddit\n\nUsers frequently report that Semax sharpens focus but can impair sleep architecture or cause early-morning awakenings if taken past midday. A subset describes poorer overall sleep quality and more intense dreaming during use. A minority mention neutral or occasionally better rest when dosed strictly in the morning, with emphasis on pairing with solid baseline habits (anecdotal tier).\n\n## What people say on X\n\nLimited public discussion specific to Semax and insomnia appears in available searches. Posts that mention the compound focus more on cognitive or mood effects than sleep outcomes (anecdotal tier, sparse data).\n\n## What we do not know\n\nNo controlled human data exist on Semax for primary insomnia. Long-term effects on sleep architecture, dose-response for any sleep-related outcomes, and interactions with common insomnia drivers remain unstudied in rigorous trials. Translation from rat BDNF data to human insomnia is speculative.\n\n## Safety and limits\n\nReported effects include nasal irritation, headache, and occasional overstimulation or sleep interference when timing is off (anecdotal and mechanistic tiers). Sources advise morning administration to avoid carryover into rest periods. Evidence base remains primarily Russian clinical use for stroke recovery plus preclinical work; large independent Western trials for sleep applications are absent. All claims above are labeled by evidence tier and separated by study type.","claims":[{"id":"c1","text":"No dedicated human clinical trials test Semax specifically for insomnia treatment.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the absence of direct evidence for the queried use case.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax increases BDNF protein levels in hippocampus and basal forebrain within hours after intranasal dosing.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Core mechanistic finding cited across multiple papers.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Small human pilots report improved attention and BDNF changes post-stroke or in healthy volunteers after intranasal Semax.","section":"What the evidence actually shows","tier":"human","source_ids":["s3","s4"],"source_status":"sourced","why_material":"Documents the limited existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users commonly report sleep disruption or insomnia when Semax is dosed later in the day.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5"],"source_status":"sourced","why_material":"Captures user-reported patterns on sleep effects.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Semax is studied primarily for cognitive recovery and BDNF support rather than sedation.","section":"Why Semax might help you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Frames the repair-versus-suppression distinction.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"Human research to suggest prevention of dementia and cognitive aging. In one pilot study in 24 healthy subjects...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16635254/","title":"Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain","quote":"Semax stimulates the synthesis of brain-derived neurotrophic factor (BDNF)...","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16996037/","title":"Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus","quote":"Semax affects cognitive brain functions by modulating the expression and the activation of the hippocampal BDNF/trkB system.","link_status":"ok","quote_status":"verified"},{"id":"s4","type":"other","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"A study of 110 patients with stroke reported that treatment with semax increased plasma BDNF levels.","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/Nootropics/comments/lfsp8z/insomnia_after_semax/","title":"Insomnia after semax?","quote":"Now i go to bed at 10pm and wake up at 3am... Semax is an ACTH fragment... stress induced insomnia with Semax.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":21472,"tokens_out":2620,"cost":0.03339,"prev_hash":"genesis","hash":"3ceb3ad1ef0cf709112014b3b6f716f0d474a5250a27e57986d42811c4d1ccb1"}],"provenance":[{"ts":"2026-06-30T00:09:04.219Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Insomnia\nSlug: semax-insomnia\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n2. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n3. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers","response":"{\"slug\":\"semax-insomnia\",\"title\":\"Semax for Insomnia: Evidence-Graded Review\",\"body\":\"## What's breaking down\\n\\nInsomnia often involves disrupted neural repair processes. BDNF levels can drop under chronic stress or cognitive load, limiting the brain's ability to form and maintain connections overnight. An ACTH fragment like Semax is studied mainly for upregulating BDNF and supporting attention and memory recovery in specific models, not for direct sedation.\\n\\nIf neural plasticity pathways are part of the picture, the discussion centers on whether targeted support there could aid recovery rather than simply suppressing wakefulness signals.\\n\\n## Why Semax might help you\\n\\n1. What keeps failing: BDNF decline and neural stress responses that interfere with the brain's overnight consolidation and repair cycles.\\n2. What Semax is studied to do: Increase BDNF protein and mRNA in rat hippocampus and basal forebrain, alongside effects on attention in small human pilots.\\n3. Therefore for you: If your insomnia links to cognitive fatigue or reduced neuroplasticity rather than pure hyperarousal, Semax enters the conversation because it is researched for repair-layer support, not because it acts as a sleep mask.\\n\\n## How these fit together\\n\\nSingle-compound focus. Semax targets the neural/cognitive layer. Any other approaches would address separate layers such as inflammation or direct sleep architecture if part of a broader profile.\\n\\n## What the evidence actually shows\\n\\nNo dedicated human clinical trials exist that test Semax specifically as a treatment for insomnia (human tier: none found).\\n\\nPreclinical tier: Rat studies demonstrate Semax binds sites in the basal forebrain and raises BDNF protein levels within hours after intranasal dosing at 50–250 µg/kg. One study showed a 1.4-fold BDNF increase in hippocampus plus elevated trkB phosphorylation and improved conditioned avoidance performance (Dolotov et al., 2006, rat model).\\n\\nAnother rat study linked Semax to ","tokens_in":21472,"tokens_out":2620,"cost":0,"prev":"genesis","hash":"de2a15fd29daf4ce9020a36a57384d536a6956c154d36a3bd99ca8cb580927ad"},{"ts":"2026-07-17T02:41:54.896Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-insomnia","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"de2a15fd29daf4ce9020a36a57384d536a6956c154d36a3bd99ca8cb580927ad","hash":"f928bdc9fb6c81e27aafbc0f8774e7fe65da41413ddb4c0ea113e588f1f0865d"}],"energy":{"passes":2,"tokens_in":21472,"tokens_out":2620,"tokens_total":24092,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"f928bdc9fb6c81e27aafbc0f8774e7fe65da41413ddb4c0ea113e588f1f0865d"},"posted_at":"2026-06-29T21:33:17.419Z","created_at":"2026-06-29T21:33:17.419Z","updated_at":"2026-07-17T02:41:54.896Z","machine":{"shape":"article.machine/v1","slug":"semax-insomnia","kind":"article","read":{"human":"https://miscsubjects.com/a/semax-insomnia","json":"https://miscsubjects.com/api/articles/semax-insomnia","bundle":"https://miscsubjects.com/api/articles/semax-insomnia/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":5,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/semax-insomnia/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=semax-insomnia","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-insomnia\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-insomnia\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/semax-insomnia/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"semax-insomnia\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/semax-insomnia | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/semax-insomnia","json":"/api/articles/semax-insomnia","markdown":"/api/articles/semax-insomnia/bundle?format=markdown","skill":"/api/articles/semax-insomnia/skill","topology":"/api/articles/semax-insomnia/topology","versions":"/api/articles/semax-insomnia/revisions","invocations":"/api/articles/semax-insomnia/invocations"},"editorial_review":null,"editorial_audit":{"slug":"semax-insomnia","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"7d01284cebcce898b0a90c3acba661b6ba72885ad193160d2d73c5929eb343e3","object":{"object_type":"article-object","identity":{"id":"article:semax-insomnia","slug":"semax-insomnia","title":"Semax for Insomnia: Evidence-Graded Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/semax-insomnia","role":"explain","audience":"human"},"skill":{"route":"/api/articles/semax-insomnia/skill","role":"direct behavior","audience":"model","content":"---\nname: semax-insomnia\ndescription: Apply the Semax for Insomnia: Evidence-Graded Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# Semax for Insomnia: Evidence-Graded Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/semax-insomnia). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/semax-insomnia.\n- Read claims and relationships at /api/articles/semax-insomnia/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Insomnia often involves disrupted neural repair processes. BDNF levels can drop under chronic stress or cognitive load, limiting the brain's ability to form and maintain connections overnight. An ACTH fragment like Sema\n\n## Representations\n\n- Human: /a/semax-insomnia\n- JSON: /api/articles/semax-insomnia\n- Relationships: /api/articles/semax-insomnia/topology\n- History: /api/articles/semax-insomnia/revisions\n"},"json":{"route":"/api/articles/semax-insomnia","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/semax-insomnia/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","semax","insomnia"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/semax-insomnia/invocations?status=success","failure_events":"/api/articles/semax-insomnia/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"semax-insomnia","title":"Semax for Insomnia: Evidence-Graded Review","body":"## What's breaking down\n\nInsomnia often involves disrupted neural repair processes. BDNF levels can drop under chronic stress or cognitive load, limiting the brain's ability to form and maintain connections overnight. An ACTH fragment like Semax is studied mainly for upregulating BDNF and supporting attention and memory recovery in specific models, not for direct sedation.\n\nIf neural plasticity pathways are part of the picture, the discussion centers on whether targeted support there could aid recovery rather than simply suppressing wakefulness signals.\n\n## Why Semax might help you\n\n1. What keeps failing: BDNF decline and neural stress responses that interfere with the brain's overnight consolidation and repair cycles.\n2. What Semax is studied to do: Increase BDNF protein and mRNA in rat hippocampus and basal forebrain, alongside effects on attention in small human pilots.\n3. Therefore for you: If your insomnia links to cognitive fatigue or reduced neuroplasticity rather than pure hyperarousal, Semax enters the conversation because it is researched for repair-layer support, not because it acts as a sleep mask.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive layer. Any other approaches would address separate layers such as inflammation or direct sleep architecture if part of a broader profile.\n\n## What the evidence actually shows\n\nNo dedicated human clinical trials exist that test Semax specifically as a treatment for insomnia (human tier: none found).\n\nPreclinical tier: Rat studies demonstrate Semax binds sites in the basal forebrain and raises BDNF protein levels within hours after intranasal dosing at 50–250 µg/kg. One study showed a 1.4-fold BDNF increase in hippocampus plus elevated trkB phosphorylation and improved conditioned avoidance performance (Dolotov et al., 2006, rat model).\n\nAnother rat study linked Semax to normalized behavior in anxiety/depression models and gene expression changes favoring neurotransmission over inflammation (preclinical tier).\n\nHuman tier: Small Russian pilots report improved attention and short-term memory after intranasal Semax (250–1000 µg/kg range) with EEG shifts resembling other neuroprotective agents. A study of 110 post-stroke patients using 6000 µg/day intranasal noted higher plasma BDNF (human tier, limited scale, stroke population). A 24-person healthy volunteer fMRI pilot showed acute changes in default mode network activity after 1.2 mg intranasal (preclinical-adjacent human data).\n\nAnecdotal tier: Multiple Reddit reports describe sleep disruption, reduced sleep quality, vivid or intense dreams, or outright insomnia when Semax is dosed in the afternoon or later. Several users note the activating profile makes late dosing counterproductive for rest (anecdotal tier).\n\n## What scientists say\n\nResearchers frame Semax as a nootropic and neuroprotective agent with BDNF-related mechanisms. Publications emphasize cognitive recovery after ischemia rather than sleep promotion. One review notes the absence of large Western RCTs for cognitive claims in healthy populations (mechanistic tier for BDNF; speculative tier for insomnia application).\n\n## What people say on Reddit\n\nUsers frequently report that Semax sharpens focus but can impair sleep architecture or cause early-morning awakenings if taken past midday. A subset describes poorer overall sleep quality and more intense dreaming during use. A minority mention neutral or occasionally better rest when dosed strictly in the morning, with emphasis on pairing with solid baseline habits (anecdotal tier).\n\n## What people say on X\n\nLimited public discussion specific to Semax and insomnia appears in available searches. Posts that mention the compound focus more on cognitive or mood effects than sleep outcomes (anecdotal tier, sparse data).\n\n## What we do not know\n\nNo controlled human data exist on Semax for primary insomnia. Long-term effects on sleep architecture, dose-response for any sleep-related outcomes, and interactions with common insomnia drivers remain unstudied in rigorous trials. Translation from rat BDNF data to human insomnia is speculative.\n\n## Safety and limits\n\nReported effects include nasal irritation, headache, and occasional overstimulation or sleep interference when timing is off (anecdotal and mechanistic tiers). Sources advise morning administration to avoid carryover into rest periods. Evidence base remains primarily Russian clinical use for stroke recovery plus preclinical work; large independent Western trials for sleep applications are absent. All claims above are labeled by evidence tier and separated by study type.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/semax-insomnia/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No dedicated human clinical trials test Semax specifically for insomnia treatment.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the absence of direct evidence for the queried use case.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax increases BDNF protein levels in hippocampus and basal forebrain within hours after intranasal dosing.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Core mechanistic finding cited across multiple papers.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Small human pilots report improved attention and BDNF changes post-stroke or in healthy volunteers after intranasal Semax.","section":"What the evidence actually shows","tier":"human","source_ids":["s3","s4"],"source_status":"sourced","why_material":"Documents the limited existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users commonly report sleep disruption or insomnia when Semax is dosed later in the day.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5"],"source_status":"sourced","why_material":"Captures user-reported patterns on sleep effects.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Semax is studied primarily for cognitive recovery and BDNF support rather than sedation.","section":"Why Semax might help you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Frames the repair-versus-suppression distinction.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"Human research to suggest prevention of dementia and cognitive aging. In one pilot study in 24 healthy subjects...","summary":"Notes limited pilot studies and absence of large Western RCTs for most claims.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:09:03.485Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"fcc0928816c885fc0e7da3346063ce0cb9ffd46aab49cae8ffc37b48e5a50bb1"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16635254/","title":"Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain","quote":"Semax stimulates the synthesis of brain-derived neurotrophic factor (BDNF)...","summary":"Rat study demonstrating BDNF increase after intranasal Semax.","claim_ids":["c2","c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:09:03.485Z","link_status":"ok","quote_status":"unverified","prev":"fcc0928816c885fc0e7da3346063ce0cb9ffd46aab49cae8ffc37b48e5a50bb1","hash":"93bb364c231fcdc75cab2fa544c0f949330c34a064e76166007060419b2c30ac"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16996037/","title":"Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus","quote":"Semax affects cognitive brain functions by modulating the expression and the activation of the hippocampal BDNF/trkB system.","summary":"Additional rat data on BDNF and cognitive tasks.","claim_ids":["c2","c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:09:03.485Z","link_status":"ok","quote_status":"verified","prev":"93bb364c231fcdc75cab2fa544c0f949330c34a064e76166007060419b2c30ac","hash":"844fcdbd290d9c1fabfc24561227bc8482ab3b9d65fc6b6a1a15d17347456fd1"},{"id":"s4","type":"other","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"A study of 110 patients with stroke reported that treatment with semax increased plasma BDNF levels.","summary":"Human post-stroke BDNF observation.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:09:03.485Z","link_status":"ok","quote_status":"unverified","prev":"844fcdbd290d9c1fabfc24561227bc8482ab3b9d65fc6b6a1a15d17347456fd1","hash":"43e507096f4bbb420e5e848c3ba5cc0036e1eb384a77d98f5ce4fac1207de794"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/Nootropics/comments/lfsp8z/insomnia_after_semax/","title":"Insomnia after semax?","quote":"Now i go to bed at 10pm and wake up at 3am... Semax is an ACTH fragment... stress induced insomnia with Semax.","summary":"User reports linking Semax to sleep disruption.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:09:03.485Z","link_status":"ok","quote_status":"unverified","prev":"43e507096f4bbb420e5e848c3ba5cc0036e1eb384a77d98f5ce4fac1207de794","hash":"a2e6b63b7511735e700324dd38d21393bb50656440331759143bb1f6a745ecef"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:09:04.219Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Semax for Insomnia: Evidence-Graded Review","register":"source_ledger","body":"## What's breaking down\n\nInsomnia often involves disrupted neural repair processes. BDNF levels can drop under chronic stress or cognitive load, limiting the brain's ability to form and maintain connections overnight. An ACTH fragment like Semax is studied mainly for upregulating BDNF and supporting attention and memory recovery in specific models, not for direct sedation.\n\nIf neural plasticity pathways are part of the picture, the discussion centers on whether targeted support there could aid recovery rather than simply suppressing wakefulness signals.\n\n## Why Semax might help you\n\n1. What keeps failing: BDNF decline and neural stress responses that interfere with the brain's overnight consolidation and repair cycles.\n2. What Semax is studied to do: Increase BDNF protein and mRNA in rat hippocampus and basal forebrain, alongside effects on attention in small human pilots.\n3. Therefore for you: If your insomnia links to cognitive fatigue or reduced neuroplasticity rather than pure hyperarousal, Semax enters the conversation because it is researched for repair-layer support, not because it acts as a sleep mask.\n\n## How these fit together\n\nSingle-compound focus. Semax targets the neural/cognitive layer. Any other approaches would address separate layers such as inflammation or direct sleep architecture if part of a broader profile.\n\n## What the evidence actually shows\n\nNo dedicated human clinical trials exist that test Semax specifically as a treatment for insomnia (human tier: none found).\n\nPreclinical tier: Rat studies demonstrate Semax binds sites in the basal forebrain and raises BDNF protein levels within hours after intranasal dosing at 50–250 µg/kg. One study showed a 1.4-fold BDNF increase in hippocampus plus elevated trkB phosphorylation and improved conditioned avoidance performance (Dolotov et al., 2006, rat model).\n\nAnother rat study linked Semax to normalized behavior in anxiety/depression models and gene expression changes favoring neurotransmission over inflammation (preclinical tier).\n\nHuman tier: Small Russian pilots report improved attention and short-term memory after intranasal Semax (250–1000 µg/kg range) with EEG shifts resembling other neuroprotective agents. A study of 110 post-stroke patients using 6000 µg/day intranasal noted higher plasma BDNF (human tier, limited scale, stroke population). A 24-person healthy volunteer fMRI pilot showed acute changes in default mode network activity after 1.2 mg intranasal (preclinical-adjacent human data).\n\nAnecdotal tier: Multiple Reddit reports describe sleep disruption, reduced sleep quality, vivid or intense dreams, or outright insomnia when Semax is dosed in the afternoon or later. Several users note the activating profile makes late dosing counterproductive for rest (anecdotal tier).\n\n## What scientists say\n\nResearchers frame Semax as a nootropic and neuroprotective agent with BDNF-related mechanisms. Publications emphasize cognitive recovery after ischemia rather than sleep promotion. One review notes the absence of large Western RCTs for cognitive claims in healthy populations (mechanistic tier for BDNF; speculative tier for insomnia application).\n\n## What people say on Reddit\n\nUsers frequently report that Semax sharpens focus but can impair sleep architecture or cause early-morning awakenings if taken past midday. A subset describes poorer overall sleep quality and more intense dreaming during use. A minority mention neutral or occasionally better rest when dosed strictly in the morning, with emphasis on pairing with solid baseline habits (anecdotal tier).\n\n## What people say on X\n\nLimited public discussion specific to Semax and insomnia appears in available searches. Posts that mention the compound focus more on cognitive or mood effects than sleep outcomes (anecdotal tier, sparse data).\n\n## What we do not know\n\nNo controlled human data exist on Semax for primary insomnia. Long-term effects on sleep architecture, dose-response for any sleep-related outcomes, and interactions with common insomnia drivers remain unstudied in rigorous trials. Translation from rat BDNF data to human insomnia is speculative.\n\n## Safety and limits\n\nReported effects include nasal irritation, headache, and occasional overstimulation or sleep interference when timing is off (anecdotal and mechanistic tiers). Sources advise morning administration to avoid carryover into rest periods. Evidence base remains primarily Russian clinical use for stroke recovery plus preclinical work; large independent Western trials for sleep applications are absent. All claims above are labeled by evidence tier and separated by study type.","claims":[{"id":"c1","text":"No dedicated human clinical trials test Semax specifically for insomnia treatment.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the absence of direct evidence for the queried use case.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Rat studies show Semax increases BDNF protein levels in hippocampus and basal forebrain within hours after intranasal dosing.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Core mechanistic finding cited across multiple papers.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Small human pilots report improved attention and BDNF changes post-stroke or in healthy volunteers after intranasal Semax.","section":"What the evidence actually shows","tier":"human","source_ids":["s3","s4"],"source_status":"sourced","why_material":"Documents the limited existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users commonly report sleep disruption or insomnia when Semax is dosed later in the day.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5"],"source_status":"sourced","why_material":"Captures user-reported patterns on sleep effects.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"Semax is studied primarily for cognitive recovery and BDNF support rather than sedation.","section":"Why Semax might help you","tier":"mechanistic","source_ids":["s2"],"source_status":"sourced","why_material":"Frames the repair-versus-suppression distinction.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:09:03.844Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"Human research to suggest prevention of dementia and cognitive aging. In one pilot study in 24 healthy subjects...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16635254/","title":"Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain","quote":"Semax stimulates the synthesis of brain-derived neurotrophic factor (BDNF)...","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/16996037/","title":"Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus","quote":"Semax affects cognitive brain functions by modulating the expression and the activation of the hippocampal BDNF/trkB system.","link_status":"ok","quote_status":"verified"},{"id":"s4","type":"other","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Semax-Cognitive-Vitality-For-Researchers.pdf","title":"Semax Cognitive Vitality For Researchers","quote":"A study of 110 patients with stroke reported that treatment with semax increased plasma BDNF levels.","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/Nootropics/comments/lfsp8z/insomnia_after_semax/","title":"Insomnia after semax?","quote":"Now i go to bed at 10pm and wake up at 3am... Semax is an ACTH fragment... stress induced insomnia with Semax.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":21472,"tokens_out":2620,"cost":0.03339,"prev_hash":"genesis","hash":"3ceb3ad1ef0cf709112014b3b6f716f0d474a5250a27e57986d42811c4d1ccb1"}],"provenance":[{"ts":"2026-06-30T00:09:04.219Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semax for Insomnia\nSlug: semax-insomnia\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"semax\",\"name\":\"Semax\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"semax\",\"name\":\"Semax\",\"section_title\":\"Why Semax might help you\",\"layer\":\"neural / cognitive\",\"steps\":[\"**What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\",\"**What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\",\"**Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\\n2. **What Semax is studied to do:** Studied for BDNF and neural support — building connections, not sedating symptoms.\\n3. **Therefore for you:** If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers","response":"{\"slug\":\"semax-insomnia\",\"title\":\"Semax for Insomnia: Evidence-Graded Review\",\"body\":\"## What's breaking down\\n\\nInsomnia often involves disrupted neural repair processes. BDNF levels can drop under chronic stress or cognitive load, limiting the brain's ability to form and maintain connections overnight. An ACTH fragment like Semax is studied mainly for upregulating BDNF and supporting attention and memory recovery in specific models, not for direct sedation.\\n\\nIf neural plasticity pathways are part of the picture, the discussion centers on whether targeted support there could aid recovery rather than simply suppressing wakefulness signals.\\n\\n## Why Semax might help you\\n\\n1. What keeps failing: BDNF decline and neural stress responses that interfere with the brain's overnight consolidation and repair cycles.\\n2. What Semax is studied to do: Increase BDNF protein and mRNA in rat hippocampus and basal forebrain, alongside effects on attention in small human pilots.\\n3. Therefore for you: If your insomnia links to cognitive fatigue or reduced neuroplasticity rather than pure hyperarousal, Semax enters the conversation because it is researched for repair-layer support, not because it acts as a sleep mask.\\n\\n## How these fit together\\n\\nSingle-compound focus. Semax targets the neural/cognitive layer. Any other approaches would address separate layers such as inflammation or direct sleep architecture if part of a broader profile.\\n\\n## What the evidence actually shows\\n\\nNo dedicated human clinical trials exist that test Semax specifically as a treatment for insomnia (human tier: none found).\\n\\nPreclinical tier: Rat studies demonstrate Semax binds sites in the basal forebrain and raises BDNF protein levels within hours after intranasal dosing at 50–250 µg/kg. One study showed a 1.4-fold BDNF increase in hippocampus plus elevated trkB phosphorylation and improved conditioned avoidance performance (Dolotov et al., 2006, rat model).\\n\\nAnother rat study linked Semax to ","tokens_in":21472,"tokens_out":2620,"cost":0,"prev":"genesis","hash":"de2a15fd29daf4ce9020a36a57384d536a6956c154d36a3bd99ca8cb580927ad"},{"ts":"2026-07-17T02:41:54.896Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-insomnia","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"de2a15fd29daf4ce9020a36a57384d536a6956c154d36a3bd99ca8cb580927ad","hash":"f928bdc9fb6c81e27aafbc0f8774e7fe65da41413ddb4c0ea113e588f1f0865d"}],"energy":{"passes":2,"tokens_in":21472,"tokens_out":2620,"tokens_total":24092,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"f928bdc9fb6c81e27aafbc0f8774e7fe65da41413ddb4c0ea113e588f1f0865d"},"posted_at":"2026-06-29T21:33:17.419Z","created_at":"2026-06-29T21:33:17.419Z","updated_at":"2026-07-17T02:41:54.896Z","machine":{"shape":"article.machine/v1","slug":"semax-insomnia","kind":"article","read":{"human":"https://miscsubjects.com/a/semax-insomnia","json":"https://miscsubjects.com/api/articles/semax-insomnia","bundle":"https://miscsubjects.com/api/articles/semax-insomnia/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":5,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/semax-insomnia/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=semax-insomnia","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-insomnia\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"semax-insomnia\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/semax-insomnia/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"semax-insomnia\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/semax-insomnia | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/semax-insomnia","json":"/api/articles/semax-insomnia","markdown":"/api/articles/semax-insomnia/bundle?format=markdown","skill":"/api/articles/semax-insomnia/skill","topology":"/api/articles/semax-insomnia/topology","versions":"/api/articles/semax-insomnia/revisions","invocations":"/api/articles/semax-insomnia/invocations"},"editorial_review":null,"editorial_audit":{"slug":"semax-insomnia","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"7d01284cebcce898b0a90c3acba661b6ba72885ad193160d2d73c5929eb343e3"}}}